LLY catalyst calendar
Clinical trials led by listed companies, by the completion date the sponsor registered on ClinicalTrials.gov, soonest first, from today. Most future dates are the sponsor's estimate and can move.
- Completion LockedPhase 1NCT02057133A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has SpreadEli Lilly and Company · Breast NeoplasmsActive, not recruitingLLYLead
- Enrollment
- Locked
- Primary completion
- Mar 15, 2021Actual
- Interventions
- Locked
- Completion LockedPhase 1NCT02779751A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast CancerEli Lilly and Company · Non Small Cell Lung CancerActive, not recruitingLLYLeadMRKCollaborator
- Enrollment
- Locked
- Primary completion
- Feb 3, 2020Actual
- Interventions
- Locked
- Completion LockedPhase 1NCT05307705A Study of LOXO-783 in Patients With Breast Cancer/Other Solid TumorsEli Lilly and Company · Breast CancerActive, not recruitingLLYLead
- Enrollment
- Locked
- Primary completion
- Apr 2, 2025Actual
- Interventions
- Locked
- Completion LockedPhase 1NCT05509790A Study of LY3484356 in Chinese Participants With Advanced Breast CancerEli Lilly and Company · Breast NeoplasmsActive, not recruitingLLYLead
- Enrollment
- Locked
- Primary completion
- Feb 18, 2024Actual
- Interventions
- Locked
- Completion LockedPhase 1NCT07225556A Study of LY4167586 in Participants With Obesity or Overweight Who Are Otherwise HealthyEli Lilly and Company · OverweightActive, not recruitingLLYLead
- Enrollment
- Locked
- Primary completion
- Dec 2026Sponsor estimate
- Interventions
- Locked
- Completion LockedPhase 1NCT07738614A Study of Eloralintide (LY3841136) in Participants With Obesity or OverweightEli Lilly and Company · ObesityActive, not recruitingLLYLead
- Enrollment
- Locked
- Primary completion
- Dec 2026Sponsor estimate
- Interventions
- Locked
- Completion LockedPhase 1NCT07803744A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or ObesityEli Lilly and Company · Diabetes Mellitus, Type 1RecruitingLLYLead
- Enrollment
- Locked
- Primary completion
- Dec 2026Sponsor estimate
- Interventions
- Locked
- Completion LockedPhase 1NCT07867327A Study of LY4515100 in Healthy Male ParticipantsEli Lilly and Company · HealthyRecruitingLLYLead
- Enrollment
- Locked
- Primary completion
- Dec 2026Sponsor estimate
- Interventions
- Locked
- Completion LockedPhase 1NCT06982859A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes...Eli Lilly and Company · Diabetes MellitusActive, not recruitingLLYLead
- Enrollment
- Locked
- Primary completion
- Jan 2027Sponsor estimate
- Interventions
- Locked
- Completion LockedPhase 1NCT07765498A Study of LY4355756 in Healthy ParticipantsEli Lilly and Company · HealthyRecruitingLLYLead
- Enrollment
- Locked
- Primary completion
- Jan 2027Sponsor estimate
- Interventions
- Locked
- Completion LockedPhase 1NCT07867340A Study of Single and Multiple Doses of LY5625573 in Healthy Participants, Including Japanese and Chinese Populations, and Participants...Eli Lilly and Company · C-Reactive ProteinRecruitingLLYLead
- Enrollment
- Locked
- Primary completion
- Jan 2027Sponsor estimate
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 11 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerHow to read this calendar
Completion dates as registered on ClinicalTrials.gov by the sponsor, for trials Signal8 links to a listed company. Most future dates are the sponsor's estimate and move. A completion date is when the last participant is measured, not when results are announced.
The window starts today. A date the sponsor registered to the day is listed when it falls inside the window; a date that has already passed is never listed as upcoming, even when the sponsor has not updated it yet. A date registered to the month only (shown as, say, Dec 2026) could be any day of that month, so it is listed only when the whole month falls inside the window. TrialScanner never adds a day the sponsor did not register.
By default the list shows trials where a listed company is the lead sponsor. Trials a listed company only collaborates on (as a partner, drug supplier or contract research organization) are added with the role filter, and every company is labelled Lead or Collaborator.
Free readers see the first 25 trials of any filter and windows up to 90 days, with the trial, phase, status, sponsor and primary completion. Enrollment, interventions, the start and completion dates, longer windows and later pages are part of the plan. See the methodology.